Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.

By A. Goldhirsch, W. Wood, R. Gelber, A. Coates, B. Thürlimann, H. Senn, Panel Members. Annals of Oncology, 2007

980 citations recorded by the source corpus.

Subfields: Cancer Research, Oncology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/87e293a0797d998e2c790617c87cddd7e7ef6149

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. O. Gluz
2. C. Liedtke
3. L. Pusztai
4. N. Gottschalk
5. U. Nitz
6. N. Harbeck

Citations in the corpus

• Triple-negative breast cancer--current status and future directions. (2009, background): “While HR are thought to mirror a good prognosis [2], expression of HER-2 has long been understood as an unfavorable prognostic feature [3].”